NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Link Cell Therapies

Link Cell Therapies

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://linkcelltx.com/

Last Round

Series A

Dec 15, 2025

Total Funding Raised

$124M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Link Cell Therapies is a biotechnology company developing next-generation CAR-T cell therapies for the treatment of solid and liquid cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyCAR-Tcancer immunotherapylogic-gated CAR-Tsynthetic biologydrug discoverybiotech startuponcology pipelineclinical trialsnext-gen CAR-Tprecision oncologybiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Link Cell Therapies Comparables

Compare Link Cell Therapies with similar companies based on industry and business-model similarity.

Link Cell Therapies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inceptor Bio
87%
ArsenalBio
85%
AvenCell
83%

Link Cell Therapies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 15, 2025
SeedMay 1, 2022

Key People

Founding team and executive leadership

Jerry Cacia

Chief Operating Officer

Executive Team

Link Cell Therapies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Grew 17% QoQ, from 24 to 28 employees.

  • Dec 15, 2025

    Raised $60M in Series A funding.

Link Cell Therapies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Link Cell Therapies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Link Cell Therapies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range28
Year Founded2022
Last FundingDec 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.